Cost, need questioned in $433-million smallpox drug deal

Spread the love
  • Yum
Share

ShareThis

Cost, need questioned in $ 433-million smallpox drug deal –A company controlled by a longtime political donor gets a no-bid contract to supply an experimental remedy for a threat that may not exist[but soon to be generated via another false flag] . 13 Nov 2011 Over the last year, the Obama administration has aggressively pushed a $ 433-million plan to buy an experimental smallpox drug, despite uncertainty over whether it is needed or will work. Senior officials have taken unusual steps to secure the contract for New York-based Siga Technologies Inc., whose controlling shareholder is billionaire Ronald O. Perelman, one of the world’s richest men and a longtime Democratic Party donor. When Siga complained that contracting specialists at the Department of Health and Human Services were resisting the company’s financial demands, senior officials replaced the government’s lead negotiator for the deal, interviews and documents show. When Siga was in danger of losing its grip on the contract a year ago, the officials blocked other firms from competing.

Citizens for Legitimate Government  
 
Play Saga First MMORTS

Print Friendly, PDF & Email

Speak Your Mind